ResearcherThe Ohio State University Wexner Medical CenterColumbus, Ohio, United States
Disclosure information not submitted.
QS210 - Chemoprevention in Familial Adenomatous Polyposis: Dual Therapy Creates Enhanced Synergy in Patient-Derived 3D Organoid Models
Monday, June 3, 20241:48 PM – 1:51 PM ET, USA